I. O. Doroshkevych
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
I. O. Doroshkevych has a total of 16 co-authors. Here are the top co-authors by number of shared publications:
- A. O. Zhamba3 shared publications
- Sviatoslav Semenenko
Вінницький національний медичний університет ім. М.І. Пирогова
3 shared publications - I. V. Oleksiienko
National Pirogov Memorial Medical University, Ukraine
2 shared publications - O. M. Semenenko
Вінницький національний медичний університет ім. М.І. Пирогова
2 shared publications A.O. Жамба
Вінницький національний медичний університет ім. М.І. Пирогова
1 shared publication- Andrii Semenenko
National Pirogov Memorial Medical University, Vinnytsya, Ukraine
1 shared publication
Latest Publications
- Open Access
- 15 June 2026
- Published by V.Danilevsky Institute for Endocrine Pathology Problems of NAMSU in PROBLEMS OF ENDOCRINE PATHOLOGY
- Vol. 83 (2) , 37-48
АГОНІСТИ РЕЦЕПТОРІВ ГПП-1: ПЕРЕВАГИ ТА РИЗИКИ
Glucagon-like peptide-1 receptor agonists (GLP-1 RA) are actively used for the treatment of type 2 diabetes mellitus and obesity. Since they effectively reduce glycemia, contribute to weight loss and improve the quality of life of patients. Despite the undeniable advantages and expansion of indications for the use of GLP-1 RA, in particular in obese patients without diabetes, there is a growing need for in-depth study of their safety profile. Purpose: to establish the advantages and disadvantages of glucagon-like peptide-1 receptor agonists using based on the analysis of scientific literature. Materials and methods. An analysis of studies in various databases was conducted, in particular Scopus, Web of Science, Google Scholar, PubMed, SpringerLink, reprotox, Medline, Cochrane Library for 2016-2026. The results of randomized clinical trials, meta-analyses and recommendations of leading diabetes associations that evaluated the effects of GLP-1 RA in patients with type 2 diabetes and obesity were analyzed. Results. GLP-1 RA have a high clinical efficacy, combining good glycemic control and significant weight loss, along with proven cardio- and renoprotective effects. Accordingly, these pharmacodynamic effects confirm the extraordinary value of GLP-1 RA in the treatment of common metabolic disorders. However, their use should be based on an individual assessment of the benefits and risks, taking into account comorbidities and individual characteristics of patients. For example, despite the metabolic benefits of obesity and type 2 diabetes pharmacotherapy, long-term use of semaglutide may have a side effect in the form of muscle loss, especially in patients with initial signs of sarcopenia and elderly people. Despite the clinical efficacy of GLP-1 RA, their effect on the exocrine function of the pancreas and a possible association with acute pancreatitis are of concern. Establishing cause-and-effect relationships is critical for patient safety, especially with risk factors. Conclusion. A comprehensive assessment of the balance of benefits and risks of long-term use of glucagon-like peptide-1 receptor agonists, establishing cause-and-effect relationships, and optimizing therapeutic approaches, especially in patients with concomitant risk factors, is critically important for improving patient safety and ensuring maximum benefit from this group of drugs.
- 15 June 2026
- Published by V.Danilevsky Institute for Endocrine Pathology Problems of NAMSU in PROBLEMS OF ENDOCRINE PATHOLOGY
- Vol. 83 (2) , 37-48
Open AccessАГОНІСТИ РЕЦЕПТОРІВ ГПП-1: ПЕРЕВАГИ ТА РИЗИКИ
Glucagon-like peptide-1 receptor agonists (GLP-1 RA) are actively used for the treatment of type 2 diabetes mellitus and obesity. Since they effectively reduce glycemia, contribute to weight loss and improve the quality of life of patients. Despite the undeniable advantages and expansion of indications for the use of GLP-1 RA, in particular in obese patients without diabetes, there is a growing need for in-depth study of their safety profile. Purpose: to establish the advantages and disadvantages of glucagon-like peptide-1 receptor agonists using based on the analysis of scientific literature. Materials and methods. An analysis of studies in various databases was conducted, in particular Scopus, Web of Science, Google Scholar, PubMed, SpringerLink, reprotox, Medline, Cochrane Library for 2016-2026. The results of randomized clinical trials, meta-analyses and recommendations of leading diabetes associations that evaluated the effects of GLP-1 RA in patients with type 2 diabetes and obesity were analyzed. Results. GLP-1 RA have a high clinical efficacy, combining good glycemic control and significant weight loss, along with proven cardio- and renoprotective effects. Accordingly, these pharmacodynamic effects confirm the extraordinary value of GLP-1 RA in the treatment of common metabolic disorders. However, their use should be based on an individual assessment of the benefits and risks, taking into account comorbidities and individual characteristics of patients. For example, despite the metabolic benefits of obesity and type 2 diabetes pharmacotherapy, long-term use of semaglutide may have a side effect in the form of muscle loss, especially in patients with initial signs of sarcopenia and elderly people. Despite the clinical efficacy of GLP-1 RA, their effect on the exocrine function of the pancreas and a possible association with acute pancreatitis are of concern. Establishing cause-and-effect relationships is critical for patient safety, especially with risk factors. Conclusion. A comprehensive assessment of the balance of benefits and risks of long-term use of glucagon-like peptide-1 receptor agonists, establishing cause-and-effect relationships, and optimizing therapeutic approaches, especially in patients with concomitant risk factors, is critically important for improving patient safety and ensuring maximum benefit from this group of drugs.
- Open Access
- 11 June 2026
- Published by Vinnytsia National Pyrogov Memorial Medical University in Reports of Vinnytsia National Medical University
- Vol. 30 (2) , 357-363
MULTIFACTORIALITY OF ALZHEIMER’S DISEASE: SCIENTIFIC AND SOCIO-ECONOMIC DIMENSION
The growth of the proportion of elderly people in the population leads to the globalization of Alzheimer’s disease (AD), which is becoming not only a medical but also a serious social, ethical and economic problem of our time. The aim of the study is a comprehensive analysis of the multifactorial nature of AD, taking into account the interaction of genetic, molecular, metabolic factors, as well as a generalization of modern approaches to early diagnosis and treatment of the disease and an assessment of its medical, social and economic impact on society, the healthcare system and patients’ families. The study was conducted in the format of a systematic review of scientific literature using the following sources: PubMed, Scopus, Web of Science and reports of international organizations for the period 2015–2026. As a result of the analysis of modern scientific data, it was established that today there are a number of pathogenetic theories of the development of AD, among which the leading ones are amyloid, tau-protein, glutamatergic, mitochondrial, metabolic and genetic hypotheses, as well as concepts related to oxidative stress and neuroinflammation. The key links of the neurodegenerative process are the accumulation of β-amyloid, pathological hyperphosphorylation of tau-protein, disruption of proteostasis, autophagy and mitophagy, which leads to destabilization of the neuronal cytoskeleton, formation of neurofibrillary tangles, synaptic dysfunction and neuronal death. Neurodegenerative changes are accompanied by disruption of cellular homeostasis and progressive damage of axons, dendrites and synapses, that justifies the need for early implementation of preventive and neuroprotective strategies to slow down the progression of the disease. At the same time, current pharmacotherapeutic approaches to the treatment of AD are mainly symptomatic and aimed at slowing down the progression of cognitive, behavioral and mental manifestations of dementia. Socio-economic analysis has revealed a significant burden on state budgets and families due to direct medical costs, loss of caregivers’ working capacity and a projected increase in costs in the coming decades. Thus, AD is a classic example of a multifactorial pathology that requires an integrated scientific and social approach.
- 11 June 2026
- Published by Vinnytsia National Pyrogov Memorial Medical University in Reports of Vinnytsia National Medical University
- Vol. 30 (2) , 357-363
Open AccessMULTIFACTORIALITY OF ALZHEIMER’S DISEASE: SCIENTIFIC AND SOCIO-ECONOMIC DIMENSION
The growth of the proportion of elderly people in the population leads to the globalization of Alzheimer’s disease (AD), which is becoming not only a medical but also a serious social, ethical and economic problem of our time. The aim of the study is a comprehensive analysis of the multifactorial nature of AD, taking into account the interaction of genetic, molecular, metabolic factors, as well as a generalization of modern approaches to early diagnosis and treatment of the disease and an assessment of its medical, social and economic impact on society, the healthcare system and patients’ families. The study was conducted in the format of a systematic review of scientific literature using the following sources: PubMed, Scopus, Web of Science and reports of international organizations for the period 2015–2026. As a result of the analysis of modern scientific data, it was established that today there are a number of pathogenetic theories of the development of AD, among which the leading ones are amyloid, tau-protein, glutamatergic, mitochondrial, metabolic and genetic hypotheses, as well as concepts related to oxidative stress and neuroinflammation. The key links of the neurodegenerative process are the accumulation of β-amyloid, pathological hyperphosphorylation of tau-protein, disruption of proteostasis, autophagy and mitophagy, which leads to destabilization of the neuronal cytoskeleton, formation of neurofibrillary tangles, synaptic dysfunction and neuronal death. Neurodegenerative changes are accompanied by disruption of cellular homeostasis and progressive damage of axons, dendrites and synapses, that justifies the need for early implementation of preventive and neuroprotective strategies to slow down the progression of the disease. At the same time, current pharmacotherapeutic approaches to the treatment of AD are mainly symptomatic and aimed at slowing down the progression of cognitive, behavioral and mental manifestations of dementia. Socio-economic analysis has revealed a significant burden on state budgets and families due to direct medical costs, loss of caregivers’ working capacity and a projected increase in costs in the coming decades. Thus, AD is a classic example of a multifactorial pathology that requires an integrated scientific and social approach.
- Open Access
- 4 February 2026
- Published by Scientific Society Anatomists, Histologists, and Embryologists, Ukraine in World of Medicine and Biology
- Vol. 22 (95) , 87-92
ВПЛИВ ГІПОГОМОЦИСТЕЇНЕМІЧНОЇ ТЕРАПІЇ НА КОГНІТИВНІ ФУНКЦІЇ У ПАЦІЄНТІВ З АРТЕРІАЛЬНОЮ ГІПЕРТЕНЗІЄЮ
Метою дослідження було оцінити вплив гіпогомоцистеїнемічної терапії на когнітивні функції у пацієнтів з артеріальною гіпертензією. Відкрите проспективне рандомізоване клінічне дослідження включало 46 пацієнтів віком 40–65 років з артеріальною гіпертензією І–ІІІ стадій залежно від наявності та ступеня ураження органів-мішеней. Пацієнти основної групи додатково отримували пероральну гіпогомоцистеїнемічну комбінацію на тлі стандартної антигіпертензивної терапії. Тривалість спостереження становила три місяці. Контрольну групу склали 34 практично здорові особи. Загальний рівень гомоцистеїну визначали методом імуноферментного аналізу до та після лікування. Обсяг короткочасної пам’яті оцінювали за тестом «10 слів» Лурії. Додавання гіпогомоцистеїнемічної терапії до стандартного антигіпертензивного лікування достовірно знижувало рівень гомоцистеїну в плазмі крові та було асоційоване з вірогідним покращенням когнітивної продуктивності. Отримані результати підтверджують потенційну нейропротекторну роль терапії, спрямованої на зниження рівня гомоцистеїну, у пацієнтів з артеріальною гіпертензією.
- 4 February 2026
- Published by Scientific Society Anatomists, Histologists, and Embryologists, Ukraine in World of Medicine and Biology
- Vol. 22 (95) , 87-92
Open AccessВПЛИВ ГІПОГОМОЦИСТЕЇНЕМІЧНОЇ ТЕРАПІЇ НА КОГНІТИВНІ ФУНКЦІЇ У ПАЦІЄНТІВ З АРТЕРІАЛЬНОЮ ГІПЕРТЕНЗІЄЮ
Метою дослідження було оцінити вплив гіпогомоцистеїнемічної терапії на когнітивні функції у пацієнтів з артеріальною гіпертензією. Відкрите проспективне рандомізоване клінічне дослідження включало 46 пацієнтів віком 40–65 років з артеріальною гіпертензією І–ІІІ стадій залежно від наявності та ступеня ураження органів-мішеней. Пацієнти основної групи додатково отримували пероральну гіпогомоцистеїнемічну комбінацію на тлі стандартної антигіпертензивної терапії. Тривалість спостереження становила три місяці. Контрольну групу склали 34 практично здорові особи. Загальний рівень гомоцистеїну визначали методом імуноферментного аналізу до та після лікування. Обсяг короткочасної пам’яті оцінювали за тестом «10 слів» Лурії. Додавання гіпогомоцистеїнемічної терапії до стандартного антигіпертензивного лікування достовірно знижувало рівень гомоцистеїну в плазмі крові та було асоційоване з вірогідним покращенням когнітивної продуктивності. Отримані результати підтверджують потенційну нейропротекторну роль терапії, спрямованої на зниження рівня гомоцистеїну, у пацієнтів з артеріальною гіпертензією.
- Open Access
- 30 December 2024
- Published by Vinnytsia National Pyrogov Memorial Medical University in Reports of Vinnytsia National Medical University
- Vol. 28 (4) , 704-707
Prospects for the development of higher medical education in the conditions of war and pandemics
Annotation. The state of higher medical education in today's conditions has undergone significant changes. The use of distance education with the involvement of modern information capabilities as an alternative to the traditional learning process has shown itself positively in the context of pandemics and full-scale Russian military aggression. But the use of such learning elements specifically among medical students has caused controversy due to the idea that in order to acquire knowledge and practical skills, physicians need to be personally present in classrooms for learning and practice. Therefore, the purpose of the article was to analyze the system of theoretical, methodological and anxiological attitudes of the development of higher medical education in the conditions of modern challenges. General scientific and theoretical pedagogical methods of research were used in order to implement the set tasks. A comprehensive analysis of the problem of organizing the training of future doctors was performed using innovative methods of organizing the educational process. In addition, the role of the teacher in today's conditions is highlighted. An analysis of the use of modern teaching methods was carried out STEM education: quest-task, training, case study. Conclusions were made regarding the comprehensive use of modern teaching methods, as this will have an impact on the formation of the level of theoretical and practical knowledge. Attention is drawn to aspects of further transformation of higher medical education in Ukraine.
- 30 December 2024
- Published by Vinnytsia National Pyrogov Memorial Medical University in Reports of Vinnytsia National Medical University
- Vol. 28 (4) , 704-707
Open AccessProspects for the development of higher medical education in the conditions of war and pandemics
Annotation. The state of higher medical education in today's conditions has undergone significant changes. The use of distance education with the involvement of modern information capabilities as an alternative to the traditional learning process has shown itself positively in the context of pandemics and full-scale Russian military aggression. But the use of such learning elements specifically among medical students has caused controversy due to the idea that in order to acquire knowledge and practical skills, physicians need to be personally present in classrooms for learning and practice. Therefore, the purpose of the article was to analyze the system of theoretical, methodological and anxiological attitudes of the development of higher medical education in the conditions of modern challenges. General scientific and theoretical pedagogical methods of research were used in order to implement the set tasks. A comprehensive analysis of the problem of organizing the training of future doctors was performed using innovative methods of organizing the educational process. In addition, the role of the teacher in today's conditions is highlighted. An analysis of the use of modern teaching methods was carried out STEM education: quest-task, training, case study. Conclusions were made regarding the comprehensive use of modern teaching methods, as this will have an impact on the formation of the level of theoretical and practical knowledge. Attention is drawn to aspects of further transformation of higher medical education in Ukraine.